This course provides an in-depth exploration of the intersection between health economics and laboratory medicine in the context of Hepatitis C Virus (HCV) screening and diagnosis.
Participants will examine the economic value of early detection, review epidemiological trends and barriers to elimination, and analyze how laboratory data influences cost-effectiveness models.
The course also covers diagnostic strategies, including screening and confirmatory methods, and emphasizes the role of laboratory-driven economic evaluations in shaping policy and resource allocation.
By integrating clinical, financial, and public health perspectives, learners will gain the knowledge to optimize HCV screening programs and support evidence-based decision-making.
